We're #hiring a new Chargé(e) de Missions Ressources Humaines France & International in St.-Germain-en-Laye, Île-de-France. Apply today or share this post with your network.
Takara Bio Europe
Biotechnology Research
Takara Bio develops high-quality innovative tools and services to accelerate discovery in life science
About us
Takara Bio Europe is a member of the Takara Bio Group, a leading supplier of tools for life scientists worldwide. We serve customers in a wide range of scientific settings, including academic institutions, government research facilities, clinical research, and pharmaceuticals in Europe, Middle East and Africa. We are a dynamic team of professionals, all dedicated to providing best-in-class solutions to research scientists in advanced biology. Quality, efficiency and the care of our customers, suppliers and staff are paramount to the way we work. With offices in Paris, France and Göteborg, Sweden, Takara Bio Europe is an outstanding place to work offering the unique opportunity to take an independent position within a European organization. We are always looking for skilled and motivated professionals. We strive to deliver innovative technologies that help push every experiment to its fullest potential. Through our brand names TAKARA®, CLONTECH® and CELLARTIS™ we develop innovative technologies in the fields of Cell Biology, Molecular Biology, Proteomics and Stem Cell Research. Key products include SMART cDNA synthesis kits, including NGS, high-performance qPCR and PCR reagents, Cellartis stem cells and stem cell reagents, RT enzymes and SMART library construction kits, the innovative In-Fusion® cloning system, Guide-it gene editing tools, Tet-based inducible gene expression systems, and Living Colors® fluorescent proteins. Recently, Takara Bio acquired Rubicon Genomics and WaferGen Bio-systems. As part of the Takara Bio family, they expand our NGS portfolio as well as add R&D, manufacturing, and support for automation systems for NGS and qPCR applications. Takara Bio’s portfolio supports applications including NGS, gene discovery, regulation, and function studies, as well as genetic analysis, protein expression and purification, gene editing, stem cell studies, and plant and food research. For more information, visit takarabio.com.
- Website
-
https://www.takarabio.com/
External link for Takara Bio Europe
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Type
- Privately Held
- Founded
- 1995
Locations
-
Primary
Get directions
-
Get directions
Arvid Wallgrens Backe 20
Göteborg, 413 46, SE
Employees at Takara Bio Europe
Updates
-
We're #hiring a new Regional Sales Manager (RSM) or Associate Regional Sales Manager (ARSM) in Germany. Apply today or share this post with your network.
-
What Makes Good Science? Good controls In our latest "That's Good Science" newsletter, Benjamin our technical support expert dives into the importance of proper controls in experiments With years of experience helping researchers optimise their experiments, he's learned firsthand how proper controls can mean the difference between a quick solution and weeks of frustration. As a bonus, he’s sharing one of his favourite examples from the “Wall of Shame.” Take a look inside!
-
We're #hiring a new Regional Sales Manager for DACH in Germany. Apply today or share this post with your network.
-
Sometimes you gotta get a lot done. With reaction times of just 12 minutes, our PrimeScript FAST RT is the fastest on the market. Want to test it for yourself? Fill in the form below, or contact your local territory manager to get a sample: 🔗 https://bit.ly/FASTestRT
-
-
PrimeCap T7 RNA Polymerase (low dsRNA), one of our newest enzymes, is optimised for researchers working in mRNA therapeutic research and development. 🧬 Key features include: 🔹 Increased capping efficiency — with up to 4-fold reductions in cap analog per reaction 🔹 Extremely low dsRNA generation — known to increase immunogenicity 🔗Find out more: https://lnkd.in/gJHjtY2B
-
-
2024 is wrapping up, and what a year it's been! From fine-tuning new experiments to embracing the occasional “unexpected” result, it’s been a year of growth, learning, and, of course, good science. Here’s to building on those lessons, tackling fresh challenges with curiosity, and making 2025 even better!
-
Do rare genetic variants hold the key to understanding immune regulation? This recently published study highlights how advanced immune profiling tools are increasingly used to uncover critical mechanisms in human immunity. By identifying the IKKαG167R variant, researchers revealed how specific disruptions in kinase activity result in severe immune abnormalities, such as autoreactive cells and missing secondary lymphoid organs. 🔗Read the paper: https://lnkd.in/gv5cK9AY #Immunology #ImmuneProfiling #PrecisionMedicine
IKKα is a master regulator of diverse biological processes, but the significance of its activity in human physiology has remained a mystery...until now 🔮⬇️ A study published in Nature Communications identified a homozygous germline variant in the kinase domain, IKKαG167R, found in three children from two unrelated Turkish families. This variant disrupts the critical (DF/LG) motif in the activation segment, eliminating kinase activity and impairing the non-canonical NF-κB pathway. The outcome? Severe immune abnormalities, including absent secondary lymphoid organs, hypogammaglobulinemia, and limited T and B cell receptor diversity marked by autoreactivity. Remarkably, while a complete loss of IKKα leads to embryonic lethality, this kinase-specific deficiency is compatible with life but wreaks havoc on immune homeostasis, revealing the indispensable, non-redundant role of IKKα kinase function in humans. Takara Bio Europe SMARTer Human TCR a/b and BCR IgG H/K/L Profiling Kit were used as powerful tools for patient's immune profiling. The figure below summarizes the molecular mechanisms of IKKαG167R and its clinical manifestations in patients.
-
-
Join The Scientist’s live symposium tomorrow, and explore how sequencing and omics are reshaping disease research. Hear from a panel of experts, including our NGS R&D Director, Dr. Yue Yan, how these technologies provide deeper insights into conditions ranging from genetic disorders to cancer. Learn about cutting-edge advancements like single-cell multi-omics and massively-parallel single-cell CRISPR screens that are driving breakthroughs in health and disease studies. 📅 Register now: https://lnkd.in/e-sgy9dQ
Exploring How Sequencing and Omics are Shaping Disease Research
the-scientist.com
-
Staying ahead in omics research means embracing the latest innovations. Hear from an expert panel, including Takara Bio’s Director of NGS R&D, Yue Yun, PhD, as they discuss new NGS platforms set to transform rare disease research. Sign up here: https://lnkd.in/e-sgy9dQ
Next-generation sequencing has revolutionized how rare diseases and cancers are understood. Sign up for this insightful virtual symposium hosted by TheScientist, where an expert panel discusses NGS platforms and complementary #omics technologies critical for advancing #RareDisease and #Cancer research: https://ow.ly/lAHg50Uh5E6 Join us to hear Dr. Yun discuss our groundbreaking Shasta™ NGS technologies and bioinformatics tools, designed to simplify the discovery of novel biomarkers.
-